The exclusive use of ECs or HTPs may be associated with reduced dental plaque and calculus accumulation compared to conventional cigarette smoking, suggesting a potentially less harmful impact on oral health. These findings could be particularly compelling for smokers concerned about dental hygiene and related issues such as bad breath.
"This forum is not just about addressing the smoking problem, but also about encouraging a comprehensive approach in public policy, advocacy, public education, and support for solutions that are lower risk and practical for adult smokers" said Ariyo.
“The examples of countries like New Zealand and Australia, geographically close but vastly different in terms of shared public policies, provide a clear picture of the global situation regarding the implementation of harm reduction policies for smoking. While Australia, committed to restrictive policies on reduced-risk products, is forced to backtrack on its positions, New Zealand, by promoting combustion-free devices as effective tools for tackling smoking, has halved the smoking rate, almost eradicating the problem,” explained Professor Polosa.
Among the numerous panels of experts from around the world who gathered to share data and future perspectives, experts and researchers from CoEHAR shared significant updates on the activities of the Catania research center conducted over the past year.
Resident doctors, PhD students, young researchers, and masters students coordinated the CoEHAR annual meeting dedicated to the World No Tobacco Day 2024, sharing experiences from their own social contexts, including…
Catania, April 29, 2024 - This morning, as part of the April graduation session of the Bachelor's Degree in Biotechnology at the University of Catania, four more theses on the…
But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.
According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.
Jeffrey Zamora, President of Asovape Costa Rica, President of ARDT Iberoamerica and Veritas's project leader, said: "We are using an innovative platform with a 2-step verification process where people will enroll in the study. After registering on the website, participants will be asked to provide information about the devices used, frequency of use, age of initiation, flavor preferences, motivations, and any cigarette consumption or experimentation. They will also complete the Respiratory Symptom Experience Scale, a validated scale that asks subjects to rate the frequency with which they had experienced any respiratory symptoms".
The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.